UroGen Pharma Ltd. Reports Q2 2026 Financial Results

What Happened
UroGen Pharma Ltd. announced its financial results for the quarter ended June 30, 2026 and filed a Form 8‑K on August 5, 2026 (Item 2.02). The company attached a press release summarizing those results as Exhibit 99.1 to the filing.

Key Details

• Filing date: August 5, 2026 (Form 8‑K, Item 2.02: Results of Operations and Financial Condition).
• Reporting period: quarter ended June 30, 2026.
• Exhibit included: Press Release dated August 5, 2026 (Exhibit 99.1).
• Interactive data: Cover Page Interactive Data File embedded in the Inline XBRL (Exhibit 104).

Why It Matters
This 8‑K communicates the company’s quarterly earnings and related financial condition information—material items investors use to assess performance. Retail investors should read the attached press release and any subsequent filings for the specific revenue, profit/loss, cash position, and management commentary, as those figures and commentary can affect valuation and trading decisions.